SCHEMBL24865014

SCHEMBL24865014

Oc1cccc(N(c2ccc(F)cc2)c2ccc(F)cc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.55
▸ CYP3A4 P08684 4/20 0.55
▸ TSHR P16473 2/20 0.50
▸ HSD17B1 P14061 7/20 0.44
▸ HSD17B2 P37059 7/20 0.44
▸ CA12 O43570 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ CA9 Q16790 2/20 0.42
▸ CA14 Q9ULX7 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ CA5B Q9Y2D0 1/20 0.42
▸ ESR2 Q92731 3/20 0.39
▸ ESR1 P03372 2/20 0.39
▸ ENPP2 Q13822 1/20 0.38
▸ MMP1 P03956 1/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ CYP2C9 P11712 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14617097 0.85 ALDH1A1 (0.56) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL8819150 0.85 ALDH1A1 (0.56) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL2355267 0.85 ALDH1A1 (0.65) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL31256035 0.85 ALDH1A1 (0.65) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL24864796 0.84 ALDH1A1 (0.50) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL3108730 0.83 HSD17B1 (0.54) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL13104523 0.83 ALDH1A1 (0.58) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL30415742 0.83 ALDH1A1 (0.58) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL1672628 0.83 ALDH1A1 (0.58) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL8721242 0.81 ALDH1A1 (0.56) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250074925-A1 RARE EARTH COMPLEX SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2025-03-06 — — US disclosed
EP-4365180-A1 RARE EARTH COMPLEX Tosoh Corporation (JP) 2024-05-08 — — EP disclosed
WO-2023282236-A1 RARE EARTH COMPLEX 東ソー株式会社 2023-01-12 — — WO disclosed
WO-2023282236-A1 RARE EARTH COMPLEX 東ソー株式会社 2023-01-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250074925-A1 RARE EARTH COMPLEX L1CAM, CHRM1, NPM1 ALDH1A1 2286/4885CYP3A4 1529/4885TSHR 1180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback